AAAAAA

   
Results: 1-10 |
Results: 10
Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: Fumonisin B-1 as an example
Authors: Dragan, YP Bidlack, WR Cohen, SM Goldsworthy, TL Hard, GC Howard, PC Riley, RT Voss, KA
Citation: Yp. Dragan et al., Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: Fumonisin B-1 as an example, TOXICOL SCI, 61(1), 2001, pp. 6-17
Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen
Authors: Divi, RL Dragan, YP Pitot, HC Poirier, MC
Citation: Rl. Divi et al., Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen, CARCINOGENE, 22(10), 2001, pp. 1693-1699
Lessons learned in applying the US EPA proposed cancer guidelines to specific compounds
Authors: Andersen, ME Meek, ME Boorman, GA Brusick, DJ Cohen, SM Dragan, YP Frederick, CB Goodman, JI Hard, GC O'Flaherty, EJ Robinson, DE
Citation: Me. Andersen et al., Lessons learned in applying the US EPA proposed cancer guidelines to specific compounds, TOXICOL SCI, 53(2), 2000, pp. 159-172
Genome-wide loss of heterozygosity analysis of chemically induced rat hepatocellular carcinomas reveals elevated frequency of allelic imbalances on chromosomes 1, 6, 8, 11, 15, 17, and 20
Authors: Teeguarden, JG Newton, MA Dragan, YP Pitot, HC
Citation: Jg. Teeguarden et al., Genome-wide loss of heterozygosity analysis of chemically induced rat hepatocellular carcinomas reveals elevated frequency of allelic imbalances on chromosomes 1, 6, 8, 11, 15, 17, and 20, MOL CARCINO, 28(1), 2000, pp. 51-61
Multiple polypeptide hormone expression in pancreatic islet cell carcinomas derived from phosphoenolpyruvatecarboxykinase-SV40 T antigen transgenic rats
Authors: Haas, MJ Sattler, CA Dragan, YP Gast, WL Pitot, HC
Citation: Mj. Haas et al., Multiple polypeptide hormone expression in pancreatic islet cell carcinomas derived from phosphoenolpyruvatecarboxykinase-SV40 T antigen transgenic rats, PANCREAS, 20(2), 2000, pp. 206-214
Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion
Authors: Dragan, YP Schrenk, D
Citation: Yp. Dragan et D. Schrenk, Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion, FOOD ADDIT, 17(4), 2000, pp. 289-302
Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats
Authors: Teeguarden, JG Dragan, YP Singh, J Vaughan, J Xu, YH Goldsworthy, T Pitot, HC
Citation: Jg. Teeguarden et al., Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats, TOXICOL SCI, 51(2), 1999, pp. 211-223
Mutational analysis of three tumor suppressor genes in two models of rat hepatocarcinogenesis
Authors: Gomez-Angelats, M Teeguarden, JG Dragan, YP Pitot, HC
Citation: M. Gomez-angelats et al., Mutational analysis of three tumor suppressor genes in two models of rat hepatocarcinogenesis, MOL CARCINO, 25(3), 1999, pp. 157-163
Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs
Authors: Haas, MJ Dragan, YP Hikita, H Shimel, R Takimoto, K Heath, S Vaughan, J Pitot, HC
Citation: Mj. Haas et al., Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs, AM J PATH, 155(1), 1999, pp. 183-192
Hormonal mechanisms in liver cancer
Authors: Dragan, YP Poole, TM Drinkwater, NR
Citation: Yp. Dragan et al., Hormonal mechanisms in liver cancer, ENDOCRINE AND HORMONAL TOXICOLOGY, 1999, pp. 309-326
Risultati: 1-10 |